Carlumab

Carlumab · Centocor Research & Development, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Carlumab, covering 2013-05-20 to 2013-05-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Efficacy of Single-agent Carlumab (an Anti-Chemokine Ligand 2 [CCL2]) in Participants With Metastatic Castrate-Resistant Prostate Cancer [Phase 2]

See pricing